NASDAQ: XENE Xenon Pharmaceuticals Inc. 8-K

Xenon Pharmaceuticals shareholders approve new 2026 equity compensation plan at annual meeting

Filed June 3, 2026 · Period ending June 2, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade XENE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 3:45 PM